Science's AIDS Prevention and Vaccine Research Site
نویسنده
چکیده
The additional risk of an infant acquiring human immunodeficiency virus type 1 (HIV) from its HIV+ mother during breast-feeding is about 15% after 24 months and depends on the duration of breast-feeding. This statistic has been exploited to inflate the disadvantages of breast-feeding. It may be more pertinent for health workers to quote a risk of about 5% if breast-feeding is practiced for 6 months, as will be the case in many programs that recommend shorter periods of breast-feeding for HIV-infected women. This review covers recent studies that highlight methodological complexities, the hazards of formula feeding in Africa, and the finding that the type of breast-feeding may influence transmission risks. Important additional risk factors include breast-milk cell-free viral load and breast health including subclinical mastitis. Interventions that have the potential to reduce breast-feeding transmission include safer obstetric practices, prevention and treatment of infant oral thrush, lactation management, shorter duration of breast-feeding, exclusive breast-feeding, antiretrovirals (to mother and infant) during breast-feeding, and heat treatment of expressed breast milk. HIV-infected mothers should be counseled to avoid any new HIV infection by abstaining from sex or using condoms.
منابع مشابه
DNA-Based Vaccine Is More Efficient than Non-Pathogenic Live Vaccine for the Prevention of HPV16 E7-Overexpressing Cancers
Introduction: Vaccinology provides promising approaches for the control of various infectious diseases. Among different strategies, DNA vaccines offer attractive research opportunities for development of vaccines for induction of antigen-specific immunity owing to their stability, simplicity of delivery, safety and cost effectiveness. However, there is a need to increase their potency by the ...
متن کاملSeropositivity among Uninfected HIV Vaccine Recipients
Marta-Louise Ackers, Bharat Parekh, Thomas G. Evans, Phillip Berman, Susan Phillips, Mary Allen, and J. Steven McDougal HIV Vaccine Section, Epidemiology Branch, Division of HIV/AIDS Prevention–Surveillance and Epidemiology, National Center for HIV, STD, and TB Prevention, and HIV Immunology and Diagnostics Branch, Division of AIDS, STD, and TB Laboratory Research, National Center for Infectiou...
متن کاملPrivate investment in AIDS vaccine development: obstacles and solutions.
The development of vaccines for the prevention of AIDS, malaria, tuberculosis, and other diseases requires both public and private investment. Private investment, however, has been far lower than might have been hoped, given the massive human toll of these diseases, particularly in the poorest countries. With a view to understanding this situation and exploring potential solutions, the World Ba...
متن کاملAIDS vaccine development: perspectives, challenges & hopes.
The worldwide quest for an AIDS vaccine represents an unprecedented scientific and human challenge for the 21st century. Preventive vaccines represent our only long-term hope to stop the epidemic. AIDS vaccines must be seen as the ultimate prevention tool that will complement the existing prevention strategies in place. The acceleration of vaccine development through the parallel exploration of...
متن کاملCloning and expression of hepatitis E virus ORF2 as a vaccine candidate
Introduction: Hepatitis E virus (HEV) is a fecal-oral transmitting virus which causes a chronic liver disease. ORF2 is an immunogen capsid protein of HEV that has been proposed to be used for Hepatitis E vaccine design. It is a 660-amino acid protein which includes an immunogenic region (residues 112-607). This protein has been expressed in complete and truncated forms, using different expressi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2001